pre_text: Stock Appreciation Rights Awards During the second quarter of fiscal 2019, in connection with the completion of the Pinnacle acquisition, we granted 2.3 million cash-settled stock appreciation rights with a fair value estimated at closing date using a Black-Scholes option-pricing model and a grant date price of $36.37 per share to Pinnacle employees in replacement of their unvested stock option awards that were outstanding as of the closing date. Approximately $14.8 million of the fair value of the replacement awards granted to Pinnacle employees was attributable to pre-combination service and was included in the purchase price and established as a liability. As of May 26, 2019, the liability of the replacement stock appreciation rights was $0.9 million, which includes post-combination service expense, the mark-to-market of the liability, and the impact of payouts since acquisition. The compensation income for our cash-settled stock appreciation rights totaled $13.7 million for fiscal 2019. Included in this amount is income of $14.0 million related to the mark-to-market of the liability established in connection with the Pinnacle acquisition and expense of $0.2 million for accelerated vesting of awards related to Pinnacle integration restructuring activities, net of the impact of marking-to-market these awards based on a lower market price of Conagra common shares. The related tax expense for fiscal 2019 was $3.4 million. A summary of the stock appreciation rights activity as of May 26, 2019 and changes during the fiscal year then ended is presented below:
table: Number of Options (in Millions) Weighted Average Exercise Price Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (in Millions)
table: Granted 2.3 $27.09
table: Exercised (0.1) $24.79 $0.1
table: Expired (1.8) $26.92
table: Outstanding at May 26, 2019 0.4 $28.13 0.16 $0.6
table: Exercisable at May 26, 2019 0.4 $28.13 0.16 $0.6
question: Analyse this data from a financial earnings document. What is the ratio of granted stocks to exercisable stocks?